137 results
Page 5 of 7
8-K
EX-99.1
zz7t g7or
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-2.1
d3w3co1an c7anrg
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
6xoii6t lj
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
7ae6xt1
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-99.1
5v3bihpt
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
8yc2ty
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.2
vw1sxil0 okh
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.1
zyj00a
15 Dec 20
Additional proxy soliciting materials
3:32pm
8-K
4h85m
9 Jul 20
Departure of Directors or Certain Officers
4:15pm
10-Q
2mom zzqfo6y
7 May 20
Quarterly report
4:37pm
8-K
f4ynq35kuxc
24 Apr 20
Submission of Matters to a Vote of Security Holders
4:38pm
DEF 14A
hhfb7o37h2vkpmc5v
6 Apr 20
Definitive proxy
6:11am
PRE 14A
ka3rl5p
30 Mar 20
Preliminary proxy
5:03pm
10-K
irnjy1
17 Mar 20
Annual report
5:27pm
8-K
w3qgmwp2s
16 Mar 20
Other Events
4:32pm
8-K
EX-99.1
rrslkpr3
4 Feb 20
TARGETING GENETICALLY - DEFINED CANCERS Corporate Presentation February 2020
12:00am
8-K
sp7s4jw
31 Jan 20
Other Events
5:01pm
6-K
EX-10.1
817vxizp
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm